A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours.
about
Oral retinoids and rexinoids in cutaneous T-cell lymphomasRegulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sitesA novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth.In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cellsDual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged SwordTargeting truncated RXRα for cancer therapy.Cessation of neoangiogenesis in Alzheimer's disease follows amyloid-beta immunizationRetinoids and rexinoids in cancer prevention: from laboratory to clinic.Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).Adjusting the compass: new insights into the role of angiogenesis in Alzheimer's diseaseCombined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics
P2860
Q26992062-3472278A-B74D-4197-897A-013684B7D688Q27025972-C41CF805-DC68-4E00-A64D-D42EB1E631BAQ33877489-A032E593-0BCF-4C16-B274-B723BC837447Q33925771-0265DB35-D0F3-4DB8-A258-3CD86EB01AE0Q35833127-B67429C6-BEE1-4C4F-A666-6270662643A9Q36183887-C1054F41-9B40-49BE-8722-35FBD82B6B6BQ36398740-03833870-EB2D-4D78-914C-960CBC025750Q36644869-CE300C8A-17E0-4204-96B4-52D94DDC4387Q36680198-0DE0B7B5-190C-4334-9EAC-7188DF1B070EQ37306894-6A593B0D-B92B-4143-9317-40E69F3E539BQ37396319-825C06B4-037E-443F-9D9D-60F9C5C2C83BQ38172335-AB7D8432-0A38-42A6-BB7B-2EF7FA0A77EBQ41819842-D99D9A29-0598-42CE-BEE8-FBA2449C34A7Q57179000-397D4B31-7CEB-4CE0-AA1A-26A8AB1D6F82
P2860
A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A selective retinoid X recepto ...... d metastasis in solid tumours.
@en
type
label
A selective retinoid X recepto ...... d metastasis in solid tumours.
@en
prefLabel
A selective retinoid X recepto ...... d metastasis in solid tumours.
@en
P2093
P2860
P356
P1476
A selective retinoid X recepto ...... d metastasis in solid tumours.
@en
P2093
A Negro-Vilar
M R Corpuz
R Y Prudente
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602995
P407
P577
2006-03-01T00:00:00Z